Fatigue News and Research

RSS

How have emergency medicine physicians' social media content and language changed during COVID-19, and can they provide insight into physician well-being?

Researchers analyzed Twitter to assess changes in the language during the coronavirus disease 2019.

12 May 2023

Targeting the hemoglobin problem in sickle cell disease using a new drug

A class of drugs used for their ability to stop tumor cells from dividing is now under study for their potential to reduce the pain and damage caused by sickle cell disease, investigators report.

11 May 2023

Pioneering AI-based approach identifies rare disease patients using electronic health records

Research paper describes the use of Symptoma's AI-based approach to identify patients with Pompe disease from retrospective electronic health records. The study found a prevalence of one in every 18,427 people for Pompe disease in the greater Salzburg region and established phenotypes for patient cohorts with an onset of symptoms above or below 1 year of age.

11 May 2023

Nervous system of people with post-Covid fatigue found to be underactive in three key areas

Experts from Newcastle University found the nervous system of people with post-Covid fatigue was underactive in three key areas. Fatigue is one of the most common symptoms of long Covid.

11 May 2023

PBMs, the brokers who control drug prices, finally get Washington’s attention

For two decades, patients and physicians eagerly awaited a lower-cost version of the world's bestselling drug, Humira, while its maker, AbbVie, fought off potential competitors by building a wall of more than 250 patents around it.

11 May 2023

Can cognitive behavioral therapy target severe fatigue following COVID-19?

Researchers examined the efficacy of cognitive behavioral therapy (CBT) for severe fatigue after COVID-19.

11 May 2023

Study documents how an investigator's sleep and fatigue can influence interrogation success

Like many first responders, law-enforcement investigators and detectives often struggle with sleep. Late-night shifts, stress, and the 24-hour nature of crime can throw off biological clocks and cut sleep cycles short.

10 May 2023

Hyperbaric oxygen therapy can be beneficial in patients with post-COVID syndrome

A small randomized trial in patients with post-COVID syndrome has found that hyperbaric oxygen therapy promotes restoration of the heart's ability to contract properly. The research is presented at EACVI 2023, a scientific congress of the European Society of Cardiology.

10 May 2023

Long COVID risk and symptoms present very differently across diverse populations, study finds

While the peak of the COVID-19 pandemic seems to have passed, the effects of post-COVID conditions on public health remain.

9 May 2023

Study may provide new avenues for addressing somatosensory symptoms of long COVID

COVID-19, the disease resulting from SARS-CoV-2 infection, is associated with highly variable clinical outcomes that range from asymptomatic disease to death.

9 May 2023

Most effective treatment for excessive daytime sleepiness found

McMaster University researchers Dena Zeraatkar and Tyler Pitre have found that the drug solriamfetol is the most effective treatment for excessive daytime sleepiness (EDS) for people with obstructive sleep apnea (OSA).

9 May 2023

Waco COVID Survey provides insights into the dynamics of COVID-19 transmission, health behaviors

Results from the Waco COVID Survey have provided needed insights into how the dynamics of COVID-19 transmission, health behaviors and COVID-19-related attitudes changed across the first two years of the pandemic in the McLennan County, Texas.

8 May 2023

Cognitive behavioral therapy is beneficial for individuals with post-viral fatigue after COVID-19

Those with post-viral fatigue after suffering from COVID-19 benefit from cognitive behavioral therapy, resulting in less fatigue and concentration problems.

8 May 2023

People with Long COVID neurological symptoms found to have differences in immune cell profiles and autonomic dysfunction

Twelve people with persistent neurological symptoms after SARS-CoV-2 infection were intensely studied at the National Institutes of Health (NIH) and were found to have differences in their immune cell profiles and autonomic dysfunction.

5 May 2023

Medical cannabis soothes cancer pain

Study evaluated the safety and effectiveness of medical cannabis in reducing pain and concurrent medications in patients with cancer. The results suggest that medical cannabis is a safe and effective complementary treatment for pain relief in patients with cancer.

4 May 2023

Millions struggle: The hidden impact of post-COVID conditions on US adults

Researchers propose a model that could be used as a foundation for future research to determine long COVID prevalence.

4 May 2023

Crohn’s disease: Symptoms, diagnosis, and treatments

Anyone newly diagnosed with Crohn's disease likely has a lot of questions – and probably some anxiety – about having a chronic ailment for which there's no cure.

4 May 2023

Innovative 3D-printed wearable sensor for sweat analysis

Sweat is more than just a sign of a good workout. It holds vital information about our health, providing clues to dehydration, fatigue, blood sugar levels and even serious conditions such as cystic fibrosis, diabetes and heart failure.

4 May 2023

HIV status does not affect Tecovirimat treatment outcomes for Mpox virus infection

A retrospective cohort study comparing the clinical presentation and treatment outcomes of people with HIV and those without HIV who were treated with tecovirimat for confirmed mpox virus infection. The study found that HIV status did not seem to affect treatment outcomes.

4 May 2023

Long term treatment with beta blockers may not be warranted in patients who don’t have heart failure

The accepted clinical practice of using beta blockers over the long term to curb the risk of further heart attacks or death doesn't seem to be warranted in patients who don't have heart failure, suggests a large study published in the journal Heart.

3 May 2023

Fatigue News and Research

How have emergency medicine physicians' social media content and language changed during COVID-19, and can they provide insight into physician well-being?

Targeting the hemoglobin problem in sickle cell disease using a new drug

Pioneering AI-based approach identifies rare disease patients using electronic health records

Nervous system of people with post-Covid fatigue found to be underactive in three key areas

PBMs, the brokers who control drug prices, finally get Washington’s attention

Can cognitive behavioral therapy target severe fatigue following COVID-19?

Study documents how an investigator's sleep and fatigue can influence interrogation success

Hyperbaric oxygen therapy can be beneficial in patients with post-COVID syndrome

Long COVID risk and symptoms present very differently across diverse populations, study finds

Study may provide new avenues for addressing somatosensory symptoms of long COVID

Most effective treatment for excessive daytime sleepiness found

Waco COVID Survey provides insights into the dynamics of COVID-19 transmission, health behaviors

Cognitive behavioral therapy is beneficial for individuals with post-viral fatigue after COVID-19

People with Long COVID neurological symptoms found to have differences in immune cell profiles and autonomic dysfunction

Medical cannabis soothes cancer pain

Millions struggle: The hidden impact of post-COVID conditions on US adults

Crohn’s disease: Symptoms, diagnosis, and treatments

Innovative 3D-printed wearable sensor for sweat analysis

HIV status does not affect Tecovirimat treatment outcomes for Mpox virus infection

Long term treatment with beta blockers may not be warranted in patients who don’t have heart failure

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News